Concourse Financial Group Securities, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 22 shares of ALNY stock, worth $6,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 21
4.76%
Holding current value
$6,079
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ALNY
# of Institutions
614Shares Held
108MCall Options Held
2.33MPut Options Held
2.17M-
Capital World Investors Los Angeles, CA15MShares$4.14 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.46 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.64 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.72 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.67 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...